Summary
This prediction ended on 01.11.22 with a price of €16.86. The prediction closed with a disappointing performance of 11.64%. BiotechBee has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| GSK plc | 4.717% | 4.717% | 43.006% | 44.227% |
| iShares Core DAX® | 1.014% | 2.699% | 4.363% | 51.689% |
| iShares Nasdaq 100 | -6.470% | -8.771% | 18.004% | 67.992% |
| iShares Nikkei 225® | -6.517% | -12.580% | 40.915% | 57.109% |
| iShares S&P 500 | -2.721% | -1.752% | 16.966% | 58.872% |
According to BiotechBee what are the pros and cons of GSK plc for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by BiotechBee for this prediction
In the thread GlaxoSmithKline plc diskutieren
Sell mit Kursziel 10,0